Cogniciti plays role in pharma’s fight against dementia

Share this
Innovation Story
Cogniciti is a free, scientifically validated test, developed by Rotman Research Institute scientists, to help adults age 40+ determine if their memory changes should be evaluated by a doctor.

“Cogniciti’s online brain health assessment offers Baycrest the chance to play a central role in the development of the next generation of Alzheimer’s disease treatment,” says Michael Meagher, president and CEO of Cogniciti.

“Finding the right research volunteers for studies has been a major problem. Through Cogniciti, users can now join a Research Registry designed to use their test results to match interested volunteers to the right studies.”
Cogniciti has signed agreements to recruit for two global drug studies and two non-drug studies at the Rotman Research Institute, all focused on therapies designed to lower the risk of Alzheimer’s Disease. Take Cogniciti’s free online Brain Health Assessment or join the Research Registry here.
 
Share this
Memory and Aging Program's Story

Memory and Aging Program gains presence online

Read Story

Don't miss out. Get news and stories from Baycrest.

Signup